Skip to main content

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/IAVGBackplate.gif

Gore acquires InnAVasc Medical, Inc., a Duke startup

Developed by Jeff Lawson, MD, PhD and Shawn Gage, PA-C in Duke University School of Medicine’s Department of Surgery, the InnAVasc device is specifically designed to allow for safe, easy, reproduceable and durable access for…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/03/radius-logo.png

Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Radius first licensed the indication for this drug discovered out of the Donald McDonnell lab from Duke in 2017.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Evecxia_Logo-1.jpg

Evecxia Therapeutics Announces Leadership Transition to Support Next Phase of Development and Growth

Joseph M. Patti, Ph.D., Appointed President and CEO John J. Kaiser, Retires as CEO, Remains as Board Director RESEARCH TRIANGLE PARK, N.C., June 13, 2022–(BUSINESS WIRE)–Evecxia Therapeutics, a clinical stage biopharmaceutical company dedicated to realizing…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Replicate-tile-1.png

Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA)

ALBANY, N.Y.,June 9, 2022–(BUSINESS WIRE)–Curia, formerly AMRI, a leading contract research, development and manufacturing organization, and Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer and to treat autoimmune and inflammatory disorders…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/green-corn-crops-field-landscape-on-bright-summer-8GFJ8AT-1.jpg

Food Sustainability in Focus

Crops around the globe face climate change and pollution, threatening our food security. With her multispectral imaging camera, Duke professor Maiken Mikkelsen sees how we can more sustainably feed the world. By Mary-Russell Roberson Synthetic…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Evecxia_Logo-1.jpg

Evecxia Therapeutics Announces Issuance of US Patent Covering EVX-101 for Depression and Other CNS Disorders

EVX-101 is a clinical-stage drug candidate currently being developed as an adjunctive treatment for when first-line antidepressants alone are inadequate. RESEARCH TRIANGLE PARK, N.C., May 24, 2022–(BUSINESS WIRE)–Evecxia Therapeutics today announced the issuance by the…

Read More

HOW FAST ARE YOU AGING?

Psychologists Terrie Moffitt and Avshalom Caspi develop a measure for your rate of aging By Duke Today Staff Five decades ago, Duke psychologists Terrie Moffitt and Avshalom Caspi began working with a long-term study of…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/DNA-STRUCTURE.png

Media Coverage: Life Science ‘Venture Day’ Shines Spotlight on 15 Triangle Startups

WRAL TechWire Covers Venture Day 2022 The innovation and entrepreneurial ecosystem across the Research Triangle is important to our regional economy. Continued growth of the ecosystem relies on collaborations among top research universities often resulting…

Read More

ClearPoint Neuro and Higgs Boson Health Announce Collaboration

The Two Companies Will Partner to Develop a Patient Facing Digital Health App for Drug Delivery and Brain Computer Interface Surgery SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT)…

Read More